Stock listing

NASDAQ:RNXT RenovoRx, Inc. Stock

Home listing (NASDAQ) of RenovoRx, Inc.

Follow RenovoRx, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:RNXT

$0.942 USD -0.178 (-15.9%)

Close on Nov 20, 2026

Past year +21.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.940 – $1.050 USDNov 20, 2026
Volume
477,326 sharesNov 20, 2026
Market cap
$45.45M USDAt the close on Nov 20, 2026 · price × 48.25M shares outstanding
52-week range
$0.770 – $2.590 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.38M USDMedian day 490,059 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
RenovoRx, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:RNXT · Home$0.942 USD-0.178 (-15.9%)477,326$1.030$1.050$0.940$1.120Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:RNXT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.942-0.178-15.9%$1.030$1.050$0.940477,326
$1.120+0.080+7.7%$1.050$1.160$1.040841,213
$1.040+0.085+8.9%$0.990$1.060$0.960490,059
$0.955-0.085-8.2%$1.010$1.059$0.900824,472
$1.040-0.120-10.3%$1.180$1.195$1.040815,137
$1.160-0.060-4.9%$1.210$1.220$1.100466,138
$1.220+0.040+3.4%$1.150$1.260$1.123256,004
$1.1800.0000.0%$1.180$1.224$1.110252,735
$1.180+0.050+4.4%$1.160$1.540$1.092844,358
$1.130-0.060-5.0%$1.050$1.205$0.8801,845,119
$1.190-0.120-9.2%$1.300$1.330$1.150341,805
$1.310+0.020+1.6%$1.330$1.370$1.270217,508
$1.290+0.030+2.4%$1.250$1.330$1.240276,187
$1.260-0.070-5.3%$1.310$1.335$1.230304,275
$1.330-0.160-10.7%$1.490$1.497$1.300376,393
$1.490+0.065+4.6%$1.430$1.510$1.430386,822
$1.425+0.035+2.5%$1.420$1.460$1.350172,958
$1.390+0.080+6.1%$1.330$1.430$1.300289,369
$1.310+0.020+1.6%$1.300$1.340$1.270181,717
$1.290+0.020+1.6%$1.250$1.310$1.250284,000
$1.270+0.040+3.3%$1.230$1.280$1.220225,700
$1.230+0.030+2.5%$1.200$1.290$1.180403,500
$1.200+0.040+3.4%$1.160$1.240$1.160264,600
$1.160+0.020+1.8%$1.150$1.200$1.140288,500
$1.140-0.050-4.2%$1.210$1.220$1.140276,800
$1.190+0.070+6.2%$1.110$1.215$1.110328,600
$1.120-0.030-2.6%$1.130$1.155$1.090624,400
$1.150-0.100-8.0%$1.243$1.270$1.135942,400
$1.250-0.030-2.3%$1.260$1.320$1.250254,100
$1.280-0.050-3.8%$1.320$1.350$1.250798,200
$1.330-0.040-2.9%$1.330$1.370$1.310438,600
$1.370-0.020-1.4%$1.350$1.410$1.275589,800
$1.390-0.080-5.4%$1.510$1.570$1.370620,900
$1.470-0.110-7.0%$1.580$1.610$1.430618,000
$1.580+0.030+1.9%$1.570$1.610$1.550269,400
$1.550-0.010-0.6%$1.570$1.590$1.500404,000
$1.560-0.010-0.6%$1.570$1.640$1.540397,200
$1.570+0.020+1.3%$1.570$1.590$1.510370,000
$1.550-0.110-6.6%$1.650$1.650$1.500876,700
$1.660-0.020-1.2%$1.690$1.725$1.645490,600
$1.680+0.050+3.1%$1.610$1.700$1.530630,000
$1.630-0.070-4.1%$1.700$1.800$1.600765,000
$1.700+0.030+1.8%$1.700$1.730$1.670383,900
$1.670-0.020-1.2%$1.690$1.740$1.630482,500
$1.690-0.040-2.3%$1.740$1.750$1.670566,800
$1.730+0.180+11.6%$1.600$1.770$1.580635,100
$1.550-0.170-9.9%$1.730$1.730$1.5501,035,400
$1.720+0.030+1.8%$1.692$1.730$1.6001,032,200
$1.690-0.070-4.0%$1.750$1.850$1.660577,900
$1.760-0.010-0.6%$1.770$1.820$1.6701,164,400
$1.770-0.225-11.3%$1.970$1.990$1.7101,636,800
$1.995-0.205-9.3%$2.150$2.300$1.9351,726,900
$2.200-0.190-7.9%$2.310$2.345$2.1511,207,100
$2.390+0.020+0.8%$2.350$2.540$2.2802,090,200
$2.370-0.150-6.0%$2.520$2.520$1.9803,818,100
$2.520+0.410+19.4%$2.140$2.590$2.1404,134,700
$2.110+0.180+9.3%$1.910$2.200$1.8303,308,300
$1.930+0.260+15.6%$1.735$1.970$1.6503,294,200
$1.670+0.190+12.8%$1.480$1.679$1.4711,054,800
$1.480-0.010-0.7%$1.470$1.550$1.430427,900
$1.490+0.070+4.9%$1.410$1.550$1.385763,800
$1.420+0.170+13.6%$1.300$1.560$1.2701,345,430
$1.250-0.070-5.3%$1.330$1.358$1.240264,048
$1.3200.0000.0%$1.300$1.325$1.250233,100
$1.320+0.005+0.4%$1.290$1.350$1.230381,200
Ticker
NASDAQ:RNXT
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All RenovoRx, Inc. news

RenovoRx, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
44 in the last 12 months · 138 in all · newest Nov 20, 2026 · oldest 2021
Calls
7 calls with a replay · 7 with a transcript · latest Nov 5, 2026
Decks
12 decks · latest November 2026

Where RenovoRx, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:RNXT · Home listing · This pageNASDAQUnited StatesUSD
BOATS:RNXTBOATSUnited StatesUSD

Valuation

EV/sales 12.7× against a median of 2.6×: the highest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$35.27M USD
P/E
Loss
EV/sales
12.7×
EV/EBITDA
Negative EBITDA
Price/book
4.9×
Gross margin
84.0%
Operating margin
−489.1%
Net margin
−469.0%
Debt to equity
0.0×
Beta vs S&P 500
1.71

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
RenovoRx, Inc. · NASDAQ:RNXTUS$45.45MUS$35.27Mn/a12.7×n/a4.9×−469.0%0.0×1.71
Medimaging Integrated Solution Inc. · TWSE:6796US$48.04MUS$43.05M111×2.1×28.6×1.9×2.1%0.5×n/a
Conexeu Sciences Inc. · NASDAQ:CNXUUS$47.79MUS$45.82Mn/an/an/a8.2×n/a0.0×2.08
Microbot Medical Inc. · NASDAQ:MBOTUS$45.67M−US$16.16Mn/a−38.6×n/a0.7×n/a0.0×1.82
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. · BIST:ONCSMUS$45.28MUS$45.31M31.7×2.9×7.5×4.5×9.0%0.1×n/a
Somnomed Limited · ASX:SOMUS$45.09MUS$37.33Mn/a0.5×8.7×1.4×−2.3%0.1×n/a
Bactiguard Holding AB · OMXSTO:BACTI_BUS$45.09MUS$54.74M76.6×2.6×12.5×1.5×2.8%0.5×n/a
Nuo Therapeutics Inc · OTC:AURXUS$44.38MUS$44.30Mn/a7.3×n/an/a−31.5%n/a0.73
Ortoma AB Class B · OMXSTO:ORT_BUS$44.22MUS$38.08Mn/a11.7×n/a2.6×−197.7%0.0×n/a
BrainCool AB · OMXSTO:BRAINUS$43.26MUS$39.04Mn/a9.8×n/a2.8×−84.7%0.0×n/a
Corentec Co., Ltd. · KRX:104540US$42.84MUS$24.22M8.5×0.3×2.3×0.7×6.4%0.0×n/a
Median of the othersUS$45.09MUS$41.05M54.1×2.6×8.7×1.9×−0.1%0.0×1.82

Forecasts

4 strong buy · Analysts' consensus from EODHD, read Nov 15, 2026. Not 6ix's view and not investment advice.

Price target
7.25 USD · Analysts' mean
EPS, year to Dec 2026
-0.27 · 1 analyst
Revenue, year to Dec 2026
3.86M · 4 analysts

Team and board

Officers

OfficerRole
Shaun R. BagaiDirector and Chief Executive Officer
Mark VollChief Financial Officer
Ronald B. KocakVice President of Finance and Controller
Tom KellyVP of Operations and Quality
Leesa GentryChief Clinical Officer
Ramtin AgahChairman, Chief Medical Officer, and Founder

Board

DirectorRole
Ramtin AgahChairman, Chief Medical Officer, and Founder
Angela MacfarlaneDirector
Laurence J. MartonDirector
Richard StarkDirector
Robert J. SpiegelDirector
Shaun R. BagaiDirector and Chief Executive Officer
Una S. RyanDirector

Events

Calls

CallWhenStatus
RenovoRx (NASDAQ:RNXT) Q3 2026 Earnings CallThu, Nov 05, 2026 · 4:30 PM ETReplay
RenovoRx (NASDAQ:RNXT) Q2 2026 Earnings CallWed, Aug 12, 2026 · 4:30 PM ETReplay
RenovoRx (NASDAQ:RNXT) Q1 2026 Earnings CallThu, May 14, 2026 · 4:30 PM ETReplay
RenovoRx (NASDAQ:RNXT) Q4 2025 Earnings CallMon, Mar 30, 2026 · 4:30 PM ETReplay
RenovoRx (NASDAQ:RNXT) Q3 2025 Earnings CallThu, Nov 13, 2025 · 4:30 PM ETReplay
RenovoRx (NASDAQ:RNXT) Q2 2025 Earnings CallThu, Aug 14, 2025 · 4:30 PM ETReplay
RenovoRx (NASDAQ:RNXT) Q1 2025 Earnings CallThu, May 15, 2025 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close−5.0%
Q2 2026Aug 12, 2026 · After close+12.5%
Q1 2026May 14, 2026 · After close−4.1%
Q3 2025Nov 13, 2025 · After close−23.0%
Q2 2025Aug 14, 2025 · After close−22.9%
Q1 2025May 15, 2025 · After close+6.3%
Q3 2024Nov 13, 2024 · After close0.0%
Q2 2024Aug 13, 2024 · After close−3.5%
Q1 2024Apr 1, 2024 · After close−6.1%
Q4 2023Mar 19, 2024 · After close+0.7%
All 20 quarters
QuarterResultsShare move
Q3 2023Nov 13, 2023 · After close−28.4%
Q2 2023Aug 16, 2023 · After close+7.6%
Q1 2023May 12, 2023 · After close+10.9%
Q4 2022Mar 2, 2023 · Before open−3.5%
Q3 2022Nov 14, 2022 · Before open+2.7%
Q2 2022Aug 12, 2022 · After close+1.5%
Q1 2022May 13, 2022 · After close0.0%
Q4 2021Mar 30, 2022 · Before open−1.3%
Quarter to Sep 30, 2021Nov 15, 2021 · After close−12.9%
Quarter to Jun 30, 2021Aug 27, 2021 · Before open+6.2%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck28 slidesNovember 2026
Investor Presentation (September 2026)Investor deck30 slidesSeptember 2026
Q2 2026 Earnings PresentationEarnings31 slidesAug 12, 2026
Q1 2026 Earnings PresentationEarnings30 slidesMay 14, 2026
Technical Presentation (February 2025)Technical17 slidesFebruary 2025
SIR 2024Conference13 slidesMar 17, 2024
Technical Presentation (2023)Technical19 slides2023
Investor Presentation (March 2022)Investor deck21 slidesMar 14, 2022
MCI Pancreas Symposium 2021Conference34 slidesNovember 2021
Technical Presentation (June 2020)Technical15 slidesJune 2020
All 12 decks
DeckKindSlidesDate
AHPBA 2017Conference20 slidesJuly 2017
Technical Presentation (April 2017)Technical20 slidesApr 2, 2017

Open Decks

Financings

RaiseDate
Public offering of common stock
Closed: US$12.1M raised · US$1.05 a share · Titan Partners Group, a division of American Capital Partners
Dealers: Titan Partners Group, a division of American Capital Partners (lead)
Use of proceeds: Working capital and general corporate purposes, including the Phase III TIGeR-PaC study and commercial sales and marketing for RenovoCath
Feb 11, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$9.00 a unit on Aug 25, 2021.

Price
US$9.00 a unit
Units offered
1,850,000 units
Offering size
US$16.6 million
Underwriters' option
Up to 277,500 more units
Listing
RNXT on the Nasdaq Capital Market
Underwriters
Roth Capital Partners, Maxim Group LLC · In the order on the cover
Units delivered
On or about Aug 30, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceApr 2, 2021
Filed publiclyJul 21, 2021
Amended 4 timesNewest Aug 25, 2021
Shares registered with an exchangeAug 11, 2021
Declared effective by the SECAug 25, 2021
Final prospectus, with the priceAug 27, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Aug 27, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue1.12M43.0K00000
Cost of revenue327.0K006.00K9.00K
Gross profit796.0K43.0K0-6.00K-9.00K
Research and development6.27M6.03M5.67M4.30M3.04M2.39M3.00M
Selling, general and administrative7.04M4.99M5.73M5.65M2.63M818.0K899.0K
Operating income-12.5M-11.0M-11.4M-9.95M-5.67M-3.20M-3.90M
Depreciation and amortization2.00M06.00K6.00K9.00K3.20M9.00K
EBITDA-10.5M-11.0M-11.4M-9.94M-5.66M0-3.89M
Interest expense384.0K108.0K57.0K904.0K590.0K0
Income before tax-11.2M-8.75M-10.2M-9.89M-6.32M-3.80M-3.84M
Income tax2.00K-8.81M-6-118.0K772.0K587.0K-63.0K
Net income-11.2M-8.81M-10.2M-9.89M-6.32M-3.80M-3.84M
Earnings per share, basic-0.32-0.40-0.99-1.09-1.21-1.72-0.22
Earnings per share, diluted-0.32-0.40-0.99-1.09-1.21-1.72

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents7.02M7.15M1.17M4.39M15.2M1.79M2.10M
Short-term investments02.05M0
Receivables139.0K43.0K0
Inventory189.0K0
Current assets7.89M7.83M1.47M7.26M16.3M1.91M2.27M
Property, plant and equipment12.0K12.0K6.00K
Total assets8.10M8.12M1.47M7.26M16.3M1.91M2.27M
Accounts payable799.0K586.0K561.0K534.0K525.0K162.0K538.0K
Current liabilities1.96M1.91M1.18M1.10M938.0K4.10M805.0K
Long-term debt23.0K
Total debt212.0K278.0K2.79M12.4M
Total liabilities2.67M3.64M4.47M1.10M938.0K4.12M805.0K
Shareholders' equity5.42M4.48M3.00M6.16M15.3M-14.7M1.47M
Shares outstanding36.6M24.0M10.7M9.10M8.93M2.23M17.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-11.0M-9.13M-10.3M-8.81M-5.92M-3.53M-3.35M
Capital spending-2.00K-12.0K00-15.0K-15.0K-15.0K
Free cash flow-11.0M-9.14M-10.3M-8.81M-5.93M-3.53M-3.35M
Cash from investing-2.00K-12.0K2.03M-2.03M-15.0K-15.0K-1.00K
Cash from financing10.8M15.1M5.01M42.0K19.3M3.20M3.20M
Change in cash-130.0K5.98M-3.22M-10.8M13.4M-329.0K-3.35M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 20, 2026Insider tradeSEC
3 · Initial statement of ownershipNov 20, 2026Insider tradeSEC
8-K · Current reportNov 20, 2026Management or board changeSEC
4 · Change in ownershipNov 17, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 6, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
RW · Request to withdraw a registrationOct 16, 2026Other filingsSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipSep 15, 2026Insider tradeSEC
8-K · Current reportAug 20, 2026Current reportSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
8-K/A · Current report, amendedAug 13, 2026ResultsSEC
8-K · Current reportAug 12, 2026Current reportSEC
8-K · Current reportAug 4, 2026Current reportSEC
8-K · Current reportJul 2, 2026Current reportSEC
S-8 · Registration statement for employee plansJun 30, 2026Offer documentSEC
8-K · Current reportJun 30, 2026Meeting outcomeSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
10-K/A · Annual report, amendedMay 15, 2026Annual reportSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
8-K · Current reportMay 14, 2026ResultsSEC
DEF 14A · Proxy statementApr 30, 2026Meeting noticeSEC
EFFECT · Notice that a registration is effectiveApr 28, 2026Other filingsSEC
424B3 · ProspectusApr 27, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 27, 2026Big-stake noticeSEC
CORRESP · Letter to the SECApr 23, 2026Other filingsSEC
UPLOAD · Letter from the SECApr 22, 2026Other filingsSEC
S-3 · Registration statementApr 16, 2026Offer documentSEC
DApr 9, 2026Other filingsSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
4 · Change in ownershipApr 7, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMar 31, 2026Offer documentSEC
8-K · Current reportMar 30, 2026ResultsSEC
10-K · Annual reportMar 30, 2026Annual reportSEC
4 · Change in ownershipMar 27, 2026Insider tradeSEC
3/A · Initial statement of ownership, amendedMar 27, 2026Insider tradeSEC
8-K · Current reportMar 27, 2026Management or board changeSEC
4 · Change in ownershipMar 24, 2026Insider tradeSEC
4 · Change in ownershipMar 24, 2026Insider tradeSEC
4 · Change in ownershipMar 24, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 24, 2026Insider tradeSEC
8-K · Current reportMar 23, 2026Material contractSEC
8-K · Current reportFeb 6, 2026Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 30, 2026Big-stake noticeSEC
4 · Change in ownershipJan 22, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 2, 2026Insider tradeSEC
8-K · Current reportJan 2, 2026Current reportSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
4 · Change in ownershipDec 19, 2025Insider tradeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
8-K · Current reportNov 14, 2025Material contractSEC
424B5 · ProspectusNov 14, 2025Offer documentSEC
S-3 · Registration statementNov 14, 2025Offer documentSEC
8-K · Current reportNov 13, 2025ResultsSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 10, 2025Big-stake noticeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
UPLOAD · Letter from the SECAug 28, 2025Other filingsSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
8-K · Current reportAug 14, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
CORRESP · Letter to the SECAug 13, 2025Other filingsSEC
UPLOAD · Letter from the SECJul 29, 2025Other filingsSEC
CORRESP · Letter to the SECJul 18, 2025Other filingsSEC
UPLOAD · Letter from the SECJul 10, 2025Other filingsSEC
4 · Change in ownershipJul 3, 2025Insider tradeSEC
4 · Change in ownershipJul 3, 2025Insider tradeSEC
4 · Change in ownershipJul 3, 2025Insider tradeSEC
4 · Change in ownershipJul 3, 2025Insider tradeSEC
S-8 · Registration statement for employee plansJun 27, 2025Offer documentSEC
8-K · Current reportJun 25, 2025Meeting outcomeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 6, 2025Insider tradeSEC
10-Q · Quarterly reportMay 15, 2025Quarterly reportSEC
8-K · Current reportMay 15, 2025ResultsSEC
SCHEDULE 13G · Big-stake noticeMay 8, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 7, 2025Big-stake noticeSEC
4 · Change in ownershipMay 6, 2025Insider tradeSEC
DEF 14A · Proxy statementApr 30, 2025Meeting noticeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
4 · Change in ownershipApr 16, 2025Insider tradeSEC
4 · Change in ownershipApr 16, 2025Insider tradeSEC
4 · Change in ownershipApr 16, 2025Insider tradeSEC
4 · Change in ownershipApr 16, 2025Insider tradeSEC
4 · Change in ownershipApr 16, 2025Insider tradeSEC
4 · Change in ownershipApr 14, 2025Insider tradeSEC
4 · Change in ownershipApr 10, 2025Insider tradeSEC
4 · Change in ownershipApr 10, 2025Insider tradeSEC
4 · Change in ownershipApr 10, 2025Insider tradeSEC
4 · Change in ownershipApr 9, 2025Insider tradeSEC
4 · Change in ownershipApr 9, 2025Insider tradeSEC
4 · Change in ownershipApr 8, 2025Insider tradeSEC
8-K · Current reportApr 1, 2025ResultsSEC
10-K · Annual reportMar 31, 2025Annual reportSEC
NT 10-K · Late filing noticeMar 31, 2025Explanation requestSEC
8-K · Current reportFeb 10, 2025Material contractSEC
424B5 · ProspectusFeb 10, 2025Offer documentSEC
424B5 · ProspectusFeb 6, 2025Offer documentSEC
8-K · Current reportNov 14, 2024ResultsSEC
10-Q · Quarterly reportNov 13, 2024Quarterly reportSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
8-K · Current reportSep 25, 2024Current reportSEC
8-K · Current reportAug 16, 2024Current reportSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
8-K · Current reportJun 7, 2024Management or board changeSEC
EFFECT · Notice that a registration is effectiveMay 13, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveMay 13, 2024Other filingsSEC
10-Q · Quarterly reportMay 10, 2024Quarterly reportSEC
424B3 · ProspectusMay 10, 2024Offer documentSEC
424B3 · ProspectusMay 10, 2024Offer documentSEC
CORRESP · Letter to the SECMay 8, 2024Other filingsSEC
CORRESP · Letter to the SECMay 8, 2024Other filingsSEC
8-K · Current reportMay 3, 2024Management or board changeSEC
UPLOAD · Letter from the SECMay 1, 2024Other filingsSEC
DEF 14A · Proxy statementApr 30, 2024Meeting noticeSEC
S-3 · Registration statementApr 26, 2024Offer documentSEC
UPLOAD · Letter from the SECApr 24, 2024Other filingsSEC
DApr 22, 2024Other filingsSEC
S-3 · Registration statementApr 19, 2024Offer documentSEC
8-K · Current reportApr 18, 2024Current reportSEC
8-K · Current reportApr 16, 2024Current reportSEC
8-K · Current reportApr 15, 2024FinancingSEC
S-8 · Registration statement for employee plansApr 12, 2024Offer documentSEC
8-K · Current reportApr 9, 2024Material contractSEC
10-K · Annual reportApr 1, 2024Annual reportSEC
8-K · Current reportMar 14, 2024Management or board changeSEC
4 · Change in ownershipMar 8, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 8, 2024Insider tradeSEC
8-K · Current reportFeb 23, 2024Management or board changeSEC
4 · Change in ownershipFeb 12, 2024Insider tradeSEC
3 · Initial statement of ownershipFeb 12, 2024Insider tradeSEC
8-K · Current reportFeb 9, 2024Management or board changeSEC
DFeb 9, 2024Other filingsSEC
4 · Change in ownershipJan 30, 2024Insider tradeSEC
4 · Change in ownershipJan 30, 2024Insider tradeSEC
4 · Change in ownershipJan 30, 2024Insider tradeSEC
4 · Change in ownershipJan 30, 2024Insider tradeSEC
4 · Change in ownershipJan 30, 2024Insider tradeSEC
8-K · Current reportJan 29, 2024Material contractSEC
4 · Change in ownershipJan 23, 2024Insider tradeSEC
4 · Change in ownershipJan 23, 2024Insider tradeSEC
4 · Change in ownershipJan 23, 2024Insider tradeSEC
8-K · Current reportJan 2, 2024Current reportSEC
8-K · Current reportDec 18, 2023Meeting outcomeSEC
DEF 14A · Proxy statementNov 27, 2023Meeting noticeSEC
PRE 14A · Preliminary proxy statementNov 17, 2023Meeting noticeSEC
8-K · Current reportNov 14, 2023ResultsSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
8-K · Current reportNov 6, 2023Current reportSEC
4 · Change in ownershipOct 4, 2023Insider tradeSEC
4 · Change in ownershipOct 2, 2023Insider tradeSEC
4 · Change in ownershipOct 2, 2023Insider tradeSEC
4 · Change in ownershipOct 2, 2023Insider tradeSEC
4 · Change in ownershipOct 2, 2023Insider tradeSEC
4 · Change in ownershipOct 2, 2023Insider tradeSEC
8-K · Current reportSep 8, 2023Current reportSEC
8-K · Current reportAug 25, 2023Current reportSEC
8-K · Current reportAug 17, 2023ResultsSEC
10-Q · Quarterly reportAug 16, 2023Quarterly reportSEC
NT 10-Q · Late filing noticeAug 15, 2023Explanation requestSEC
8-K · Current reportJun 29, 2023Current reportSEC
8-K · Current reportJun 9, 2023Meeting outcomeSEC
EFFECT · Notice that a registration is effectiveMay 22, 2023Other filingsSEC
424B3 · ProspectusMay 19, 2023Offer documentSEC
CORRESP · Letter to the SECMay 17, 2023Other filingsSEC
UPLOAD · Letter from the SECMay 16, 2023Other filingsSEC
8-K · Current reportMay 15, 2023ResultsSEC
S-3 · Registration statementMay 12, 2023Offer documentSEC
10-Q · Quarterly reportMay 12, 2023Quarterly reportSEC
DEF 14A · Proxy statementMay 1, 2023Meeting noticeSEC
4 · Change in ownershipApr 27, 2023Insider tradeSEC
3 · Initial statement of ownershipApr 27, 2023Insider tradeSEC
8-K · Current reportApr 27, 2023Management or board changeSEC
8-K · Current reportApr 3, 2023Material contractSEC
424B5 · ProspectusApr 3, 2023Offer documentSEC
S-8 POSMar 31, 2023Offer documentSEC
S-8 · Registration statement for employee plansMar 31, 2023Offer documentSEC
10-K · Annual reportMar 31, 2023Annual reportSEC
4 · Change in ownershipMar 29, 2023Insider tradeSEC
4 · Change in ownershipMar 29, 2023Insider tradeSEC
4 · Change in ownershipMar 29, 2023Insider tradeSEC
8-K · Current reportMar 2, 2023ResultsSEC

This page holds 200 of 297 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from RenovoRx, Inc.’s releases · as of Oct 30, 2026

Common shares
48,250,592
Fully diluted
48,250,592

Fully diluted

LineSharesAs of
Common shares48,250,592Oct 30, 2026

Share count over time

CountShares
Oct 30, 202648,250,592

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
AIGH Capital Management LLC4.26M8.8%US$6.65MSep 30, 2026
Vanguard1.96M4.1%US$3.05MSep 30, 2026
Bleichroeder LP1.67M3.5%US$2.6MSep 30, 2026
Renaissance Technologies1.12M2.3%US$1.75MSep 30, 2026
Geode Capital473K0.98%US$738KSep 30, 2026
State Street315K0.65%US$491KSep 30, 2026
Informed Momentum Co LLC273K0.57%US$425KSep 30, 2026
Walleye Capital LLC262K0.54%US$409KSep 30, 2026
Wealthspire Advisors, LLC253K0.52%US$394KSep 30, 2026
Bank of America194K0.40%US$303KSep 30, 2026
All 37 holders
HolderSharesOf the companyValueAs of
Two Sigma194K0.40%US$302KSep 30, 2026
Sei Investments Co165K0.34%US$257KSep 30, 2026
Jane Street152K0.32%US$237KSep 30, 2026
Hrt Financial LP139K0.29%US$217KSep 30, 2026
Citadel104K0.22%US$162KSep 30, 2026
T3 Companies, LLC96,8000.20%US$151KSep 30, 2026
Chicago Partners Investment Group LLC92,3560.19%US$119KSep 30, 2026
Northern Trust85,2070.18%US$133KSep 30, 2026
Northwestern Mutual Wealth Management Co74,5960.15%US$116KSep 30, 2026
Connective Capital Management, LLC58,7320.12%US$91,622Sep 30, 2026
Cetera Investment Advisers57,9760.12%US$90,443Sep 30, 2026
UBS51,2390.11%US$79,933Sep 30, 2026
Raymond James Financial Inc45,7000.09%US$71,292Sep 30, 2026
Kestra Advisory Services, LLC37,5200.08%US$58,531Sep 30, 2026
Clear Creek Financial Management, LLC36,7060.08%US$57,262Sep 30, 2026
HighTower Advisors, LLC20,0000.04%US$31,200Sep 30, 2026
XTX Topco Ltd14,0810.03%US$21,966Sep 30, 2026
Affinity Capital Advisors, LLC13,2790.03%US$16,997Sep 30, 2026
StoneX Group Inc.12,5780.03%US$22,038Sep 30, 2026
Captrust Financial Advisors12,3070.03%US$19,199Sep 30, 2026
Jones Financial Companies Lllp11,8900.02%US$19,737Sep 30, 2026
Focus Partners Wealth11,0000.02%US$17,160Sep 30, 2026
Morgan Stanley7,1020.01%US$11,079Sep 30, 2026
Tower Research Capital LLC (TRC)4,527<0.01%US$7,062Sep 30, 2026
Pinnacle Financial Group, Inc.1,000<0.01%US$1,560Sep 30, 2026
Caitong International Asset Management Co., Ltd44<0.01%US$69Sep 30, 2026
Fidelity38<0.01%US$59Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund1.03M2.1%US$1.01MJun 30, 2026
Vanguard Extended Market Index Fund380K0.79%US$372KJun 30, 2026
Fidelity Extended Market Index Fund178K0.37%US$162KMay 31, 2026
Fidelity Total Market Index Fund77,9820.16%US$70,917May 31, 2026
Fidelity Series Total Market Index Fund49,5550.10%US$45,065May 31, 2026
Vanguard Balanced Index Fund29,6280.06%US$29,035Jun 30, 2026
Fidelity Nasdaq Composite Index Fund20,4770.04%US$18,622May 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Agah Ramtin
Director, Officer: Executive Chairman and CMO
Buy50,000USD 0.93US$46,485Nov 16, 2026
Voll Mark
Officer: Chief Financial Officer
Buy25,000USD 0.79US$19,750May 19, 2026

Big stakes

StakeStakeSharesDateFiling
Orin Hirschman9.80%4.43MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robert J. Spiegel
Other companies: Ernexa Therapeutics Inc. (Director · Since at least Sep 14, 2026); Geron Corporation (Director · Since at least Sep 29, 2017); Athenex Inc (Director · Aug 4, 2020 – Apr 21, 2023 · Past); Ayala Pharmaceuticals Inc (Director · May 7, 2020 – Jan 19, 2023 · Past); Bio Green Med Solution, Inc. (Director · Sep 6, 2018 – Jun 30, 2023 · Past); PDS Biotechnology Corporation (Director · Jun 19, 2018 – Mar 15, 2019 · Past); Sucampo Pharmaceuticals Inc (Director · Feb 13, 2018 – Feb 13, 2018 · Past)
Director · Since at least Apr 25, 2023
James M. Ahlers
Other companies: Cue Biopharma, Inc. (Chief Financial Officer · Since at least Jul 30, 2026); Intensity Therapeutics, Inc. (Executive Vice President · Since at least Jun 29, 2023)
Chief Financial Officer · Jul 15, 2022 – Jul 15, 2022 · Past
Laurence J. Marton
Other companies: Matternet Inc (Director · Since at least May 22, 2026)
Director · Since at least Apr 8, 2025
Angela MacfarlaneDirector · Since at least Nov 20, 2026
Angela NelmsChief Operating Officer · Sep 19, 2022 – Jan 19, 2024 · Past
Leesa GentryChief Clinical Officer · Since at least Mar 1, 2024
Mark VollChief Financial Officer · Since at least Feb 5, 2026
Phil StoctonVice President of Sales and Market Development · Aug 14, 2025 – Nov 20, 2026 · Past
Ramtin AgahChairman, Chief Medical Officer, and Founder · Since at least Feb 27, 2026
Richard StarkDirector · Since at least Nov 19, 2026
All 14 people
PersonSeat
Ronald B. KocakVice President of Finance and Controller · Since at least Feb 5, 2026
Shaun R. BagaiDirector and Chief Executive Officer · Since at least Aug 25, 2021
Tom KellyVP of Operations and Quality · Since at least Nov 20, 2026
Una S. RyanDirector · Since at least Mar 3, 2022

Open People

Log in to ask 6ix AI your own questions about RenovoRx, Inc.